First Capital Inc: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 14, 2025 and accepted by EDGAR at May 14, 2025, 16:31 ET.
Management's discussion and analysis
As filed, 840 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
| Period | (a) Total Number of Shares Purchased | (b) Average Price Paid Per Share | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
|---|---|---|---|---|
| January 1 through January 31, 2025 | - | N/A | - | 113,721 |
| February 1 through February 28, 2025 | - | N/A | - | 113,721 |
| March 1 through March 31, 2025 | 250 | $37.90 | 250 | 113,471 |
| Total | 250 | $37.90 | 250 |
On August 19, 2008, the board of directors authorized the repurchase of up to 240,467 shares of the Company’s outstanding common stock. The stock repurchase program will expire upon the purchase of the maximum number of shares authorized under the program, unless the board of directors terminates the program earlier.
Risk factors
As filed, 422 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Recent changes in international trade regulation or foreign trade policy, including tariffs, could lead to higher than anticipated inflation and supply chain disruption, which may impact consumer and commercial borrower performance.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $1.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months2025-01-01 to 2025-03-31 | $3.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-01-01 to 2025-03-31 | $672.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | $3.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | $0.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | $0.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 3,348,298 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | $4.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-01-01 to 2025-03-31 | $220.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2025-01-01 to 2025-03-31 | $974.0k | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2025-01-01 to 2025-03-31 | $9.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2025-03-31 | $1.21bn | us-gaap:Assets |
| Total liabilities | At period end2025-03-31 | $1.09bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $120.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001171843-25-003186. Last ingested by Listed: Nov 6, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.